Literature DB >> 9665144

Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.

P P Leong1, B Rezai, W M Koch, A Reed, D Eisele, D J Lee, D Sidransky, J Jen, W H Westra.   

Abstract

BACKGROUND: In patients with head and neck squamous cell carcinoma (HNSCC), a squamous cell carcinoma (SCC) in the lung represents either another primary tumor or a metastasis. This distinction greatly influences patient prognosis and could guide treatment strategies, but the nature of a solitary lung nodule is often difficult to discern by use of standard clinical and histologic parameters. Comparison of genetic alterations in the tumors could resolve this dilemma.
METHODS: We compared paired tumors from 16 patients with HNSCC and a solitary lung SCC for loss (i.e., deletion) of loci on chromosomal arms 3p and 9p. Losses at these loci occur early during neoplastic transformation of the respiratory tract. DNA from microdissected tumors and normal tissues was subjected to polymerase chain reaction-based microsatellite analysis. An effort was also made to distinguish primary lung cancers from lung metastases on the basis of clinical and histopathologic features.
RESULTS: In most cases, comparison of genetic alterations clarified the relationship between the lung tumor and the primary HNSCC. The paired tumors from 10 patients had concordant patterns of loss at all loci suggesting metastatic spread, whereas three paired tumors had discordant patterns of loss at all loci suggesting independent tumor origin. These observations were supported by the clinical and pathologic findings. CONCLUSIONS/IMPLICATIONS: In patients with HNSCC and a solitary SCC in the lung, microsatellite analysis provides a rapid genetic approach for discerning clonal relationships. In such patients, we found that a solitary SCC in the lung more likely represents a metastasis than an independent lung cancer. Microsatellite analysis could potentially be applied to any patient with multiple tumors, where tumor relationships are not clear on clinical, radiographic, or even histopathologic grounds.

Entities:  

Mesh:

Year:  1998        PMID: 9665144     DOI: 10.1093/jnci/90.13.972

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  27 in total

1.  The role of (18)F-FDG PET in the differentiation between lung metastases and synchronous second primary lung tumours.

Authors:  Bernadette G Dijkman; Olga C J Schuurbiers; Dennis Vriens; Monika Looijen-Salamon; Johan Bussink; Johanna N H Timmer-Bonte; Miranda M Snoeren; Wim J G Oyen; Henricus F M van der Heijden; Lioe-Fee de Geus-Oei
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-10       Impact factor: 9.236

2.  PARD3 Inactivation in Lung Squamous Cell Carcinomas Impairs STAT3 and Promotes Malignant Invasion.

Authors:  Ester Bonastre; Sara Verdura; Ilse Zondervan; Federica Facchinetti; Sylvie Lantuejoul; Maria Dolores Chiara; Juan Pablo Rodrigo; Julian Carretero; Enric Condom; Agustin Vidal; David Sidransky; Alberto Villanueva; Luca Roz; Elisabeth Brambilla; Suvi Savola; Montse Sanchez-Cespedes
Journal:  Cancer Res       Date:  2015-04-01       Impact factor: 12.701

3.  Testing clonal relatedness of tumors using array comparative genomic hybridization: a statistical challenge.

Authors:  Irina Ostrovnaya; Colin B Begg
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

4.  Comparison of properties of tests for assessing tumor clonality.

Authors:  Irina Ostrovnaya; Venkatraman E Seshan; Colin B Begg
Journal:  Biometrics       Date:  2008-02-11       Impact factor: 2.571

Review 5.  The pivotal role of pathology in the management of lung cancer.

Authors:  Morgan R Davidson; Adi F Gazdar; Belinda E Clarke
Journal:  J Thorac Dis       Date:  2013-10       Impact factor: 2.895

6.  Ability of FDG PET and CT radiomics features to differentiate between primary and metastatic lung lesions.

Authors:  Margarita Kirienko; Luca Cozzi; Alexia Rossi; Emanuele Voulaz; Lidija Antunovic; Antonella Fogliata; Arturo Chiti; Martina Sollini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-06       Impact factor: 9.236

Review 7.  Open questions and novel concepts in oral cancer surgery.

Authors:  Giancarlo Tirelli; Serena Zacchigna; Matteo Biasotto; Marco Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-24       Impact factor: 2.503

Review 8.  Molecular biology of squamous cell carcinoma of the head and neck.

Authors:  B Perez-Ordoñez; M Beauchemin; R C K Jordan
Journal:  J Clin Pathol       Date:  2006-05       Impact factor: 3.411

9.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

10.  Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.

Authors:  Irene Orlow; Diana V Tommasi; Bradley Bloom; Irina Ostrovnaya; Javier Cotignola; Urvi Mujumdar; Klaus J Busam; Achim A Jungbluth; Richard A Scolyer; John F Thompson; Bruce K Armstrong; Marianne Berwick; Nancy E Thomas; Colin B Begg
Journal:  J Invest Dermatol       Date:  2009-03-12       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.